| Code | 8901B | ||||||||||
| MA number | 34/0179/16-S | ||||||||||
| Product Form: | sol iru 1x5 ml/250 mg (striek.inj.napl.+ihla) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | TEVA Pharmaceuticals Slovakia s.r.o., Slovakia | ||||||||||
| Therapeutic Class: | 34 - ANTIHORMONA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | pre-filled syringe | ||||||||||
| Route of admin.: | Intramuscular use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 12.04.2016 |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Fulvestrant Teva 250 mg_03_2021.pdf
|
| PIL: |
PIL_Fulvestrant Teva 250 mg_03_2021.pdf
|
| Safety feature | Yes |
| Data update: | 19.11.2020 |
